According to Nykode Therapeutics's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 34.7098. At the end of 2023 the company had a P/S ratio of 47.8.
Year | P/S ratio | Change |
---|---|---|
2023 | 47.8 | -59.14% |
2022 | 117 | 49.66% |
2021 | 78.2 |